Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/6/2018
SIETES contiene 92381 citas

 
 
 1 a 20 de 1254 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Salm-Reifferscheidt L. Tramadol: Africa's opioid crisis. Lancet 2018;391:19 de mayo. [Ref.ID 102613]
2. Cita con resumen
Hirschler B. Regulators flag possible birth defect link to GSK's HIV drug. Reuters Health News 2018:18 de mayo. [Ref.ID 102606]
3. Cita con resumen
Anónimo. GSK cuts back operations in Africa. DIA Daily 2018:1. [Ref.ID 102445]
6. Cita con resumen
Anónimo. Vaccin paludique RTS,S/AS01E. Prescrire 2016;36:725-6. [Ref.ID 100886]
7.Tiene citas relacionadas Cita con resumen
Larsen TB, Nielsen PB. Stroke and mortality after atrial fibrillation—a global struggle. Lancet 2016;388:1131-2. [Ref.ID 100749]
8.Tiene citas relacionadas Cita con resumen
Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, Commerford P, Jansky P, Avezum A, Sigamani A, Demasceno A, Reilly P, Grinvalds A, Nakamya J, Aje A, Almahmeed W, Moriarty A, Wallentin L, Yusuf S, Connolly SJ, on behalf of the RE-LY Atrial Fibrillation Registry and Cohort Study Investigators. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet 2016;388:1161-9. [Ref.ID 100676]
9. Cita con resumen
Diacon AH, van der Merwe L, Barnard M, von Groote-Bidlingmaier F, Lange C, García-Basteiro AL, Sevene E, Ballell L, Barros-Aguirre D. ß-lactams against tuberculosis — New trick for an old dog?. N Engl J Med 2016;375:393-4. [Ref.ID 100492]
10.Enlace a cita original Cita con resumen
González R, Sevene E, Jagoe G, Slutsker L, Menéndez C. A public health paradox: the women most vulnerable to malaria are the least protected. PLOS Medicine 2016:3 de mayo. [Ref.ID 100350]
12. Cita con resumen
Anónimo. GSK conducting internal review of bribery allegations In Yemen. DIA Daily 2016:1. [Ref.ID 100120]
13. Cita con resumen
Anónimo. What next for the malaria RTS,S vaccine candidate?. Lancet 2015;386:1708. [Ref.ID 99666]
14. Cita con resumen
Maurice J. And then there were two…polio-endemic countries. Lancet 2015;386:1521-2. [Ref.ID 99659]
15.Tiene citas relacionadas Cita con resumen
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé GN, Soumah A, Trelle S, Vicari AS, Watson CH, Kieny MP, Rottingen J-A. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-66. [Ref.ID 99512]
16.Tiene citas relacionadas Cita con resumen
Anónimo. An ebola vaccine: first results and promising opportunities. Lancet 2015;386:830. [Ref.ID 99511]
18.Tiene citas relacionadas
Moorthy VS, Okwo-Bele J-M. Final results from a pivotal phase 3 malaria vaccine trial. Lancet 2015;386:5-7. [Ref.ID 99327]
20. Cita con resumen
Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J. Methodological approaches to evaluate the impact of FDA drug safety communications. Drug Saf 2015;38:565-75. [Ref.ID 99239]
Seleccionar todas
 
 1 a 20 de 1254 siguiente >>